U.S. flag

An official website of the United States government

NM_024876.4(COQ8B):c.532C>T (p.Arg178Trp) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004019521.1

Allele description [Variation Report for NM_024876.4(COQ8B):c.532C>T (p.Arg178Trp)]

NM_024876.4(COQ8B):c.532C>T (p.Arg178Trp)

Gene:
COQ8B:coenzyme Q8B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_024876.4(COQ8B):c.532C>T (p.Arg178Trp)
HGVS:
  • NC_000019.10:g.40705140G>A
  • NG_027800.1:g.16746C>T
  • NM_001142555.3:c.409C>T
  • NM_024876.4:c.532C>TMANE SELECT
  • NP_001136027.1:p.Arg137Trp
  • NP_079152.3:p.Arg178Trp
  • NP_079152.3:p.Arg178Trp
  • NC_000019.9:g.41211045G>A
  • NM_001142555.2:c.409C>T
  • NM_024876.3:c.532C>T
  • Q96D53:p.Arg178Trp
Protein change:
R137W; ARG178TRP
Links:
UniProtKB: Q96D53#VAR_070552; OMIM: 615567.0001; dbSNP: rs398122978
NCBI 1000 Genomes Browser:
rs398122978
Molecular consequence:
  • NM_001142555.3:c.409C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024876.4:c.532C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004850475Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Nov 3, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, et al.

J Clin Invest. 2013 Dec;123(12):5179-89. doi: 10.1172/JCI69000. Epub 2013 Nov 25.

PubMed [citation]
PMID:
24270420
PMCID:
PMC3859425

A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytes.

Maeoka Y, Doi T, Aizawa M, Miyasako K, Hirashio S, Masuda Y, Kishita Y, Okazaki Y, Murayama K, Imasawa T, Hara S, Masaki T.

BMC Nephrol. 2020 Aug 28;21(1):376. doi: 10.1186/s12882-020-02040-z.

PubMed [citation]
PMID:
32859164
PMCID:
PMC7456044
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV004850475.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The c.532C>T (p.R178W) alteration is located in exon 7 (coding exon 6) of the COQ8B gene. This alteration results from a C to T substitution at nucleotide position 532, causing the arginine (R) at amino acid position 178 to be replaced by a tryptophan (W). Based on data from gnomAD, the T allele has an overall frequency of 0.003% (7/279154) total alleles studied. The highest observed frequency was 0.02% (4/19808) of East Asian alleles. This alteration was detected in the homozygous state in multiple individuals with COQ8B-related primary coenzyme Q10 deficiency (Al-Hamed, 2022; Alvi, 2022; Maeoka, 2020; Ashraf, 2013). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 3, 2025